Orient Europharma Co Ltd (4120) — Cash Flow-to-Debt Ratio
Orient Europharma Co Ltd (4120) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of NT$-157.84 Million could theoretically repay 0% of its total liabilities (NT$4.54 Billion) in one year. See Orient Europharma Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Orient Europharma Co Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Orient Europharma Co Ltd across 10 annual periods. Also explore how fast is Orient Europharma Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Orient Europharma Co Ltd (2015–2024)
Year-by-year debt coverage analysis for Orient Europharma Co Ltd. For market capitalisation and broader financial context, see Orient Europharma Co Ltd (4120) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.02x | NT$-121.11 Million | NT$5.75 Billion | ▼ -316.7% |
| 2023 | 0.01x | NT$64.67 Million | NT$6.65 Billion | ▲ +131.1% |
| 2022 | -0.03x | NT$-218.75 Million | NT$6.99 Billion | ▼ -339.9% |
| 2021 | 0.01x | NT$77.65 Million | NT$5.95 Billion | ▼ -90.9% |
| 2020 | 0.14x | NT$608.55 Million | NT$4.25 Billion | ▲ +155.5% |
| 2019 | 0.06x | NT$227.37 Million | NT$4.06 Billion | ▼ -25.0% |
| 2018 | 0.07x | NT$231.31 Million | NT$3.10 Billion | ▼ -68.2% |
| 2017 | 0.24x | NT$601.08 Million | NT$2.56 Billion | ▲ +443.4% |
| 2016 | 0.04x | NT$111.24 Million | NT$2.57 Billion | ▼ -86.0% |
| 2015 | 0.31x | NT$643.97 Million | NT$2.09 Billion | — |